IP Library › Granted Patent US 7,662,101
Granted Patent B2
US 7,662,101 · App. 10/930,346 · Granted Feb 16, 2010

Therapy control based on cardiopulmonary status

Assignee: Cardiac Pacemakers, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,662,101
App. No.
10/930,346
Granted
Feb 16, 2010
Kind
B2
Abstract

Methods and systems provide an approach to therapy control based on assessment of a patient's cardiopulmonary status. Conditions sensed via sensors of an external respiratory therapy device are used to assess a patient's cardiopulmonary status. The respiratory therapy device sensors may be utilized alone or in combination with other sensors to determine cardiopulmonary status of a patient. Therapy delivered to the patient is controlled based on the cardiopulmonary status assessment. For example, therapy delivered to the patient may be initiated, terminated, and/or modified based on the assessed cardiopulmonary status of the patient. Cardiopulmonary status assessment, therapy control, or both, are performed by an implantable device.

Claims (34)

1. A medical therapy control system, comprising:

an external respiratory therapy device comprising a first sensor system configured to sense a first set of one or more physiological conditions and a therapy unit configured to provide positive airway pressure to a patient;

an implantable cardiac therapy device comprising a second sensor system configured to sense a second set of one or more physiological conditions and a therapy unit configured to deliver electrical stimulation to the patient's heart;

a cardiopulmonary disorder processor coupled to the first and the second sensor systems and configured to detect rhythm breathing disorders, including at least apnea, and non-rhythm breathing disorders, including one or more pulmonary vasculature disorders, based on changes in the first set and the second set of sensed physiological conditions, the cardiopulmonary disorder processor configured to identify a cardiopulmonary disorder affecting a patient as a breathing rhythm disorder or a non-rhythm breathing disorder; and

a therapy controller coupled to the cardiopulmonary disorder processor and configured to control a therapy delivered to the patient based on the identified cardiopulmonary disorder, wherein at least one of the cardiopulmonary disorder processor and the therapy controller are disposed within the implantable cardiac therapy device;

wherein the cardiopulmonary disorder processor is further configured to detect one or more infectious pulmonary disorders based on the first set and the second set of sensed physiological conditions and to identify the cardiopulmonary disorder as the breathing rhythm disorder, the non-rhythm breathing disorder, or an infectious pulmonary disorder;

wherein the one or more infectious pulmonary disorders comprise one or more of bronchitis, pneumonia, bronchiolitis, tuberculosis, and bronchiectasis; and

wherein the cardiopulmonary disorder processor is further configured to identify the infectious pulmonary disorder as bronchitis, pneumonia, bronchiolitis, tuberculosis, or bronchiectasis.

2. A medical therapy control system, comprising:

an external respiratory therapy device comprising a first sensor system configured to sense a first set of one or more physiological conditions and a therapy unit configured to provide positive airway pressure to a patient;

an implantable cardiac therapy device comprising a second sensor system configured to sense a second set of one or more physiological conditions and a therapy unit configured to deliver electrical stimulation to the patient's heart;

a cardiopulmonary disorder processor coupled to the first and the second sensor systems and configured to detect rhythm breathing disorders, including at least apnea, and non-rhythm breathing disorders, including one or more pulmonary vasculature disorders, based on changes in the first set and the second set of sensed physiological conditions, the cardiopulmonary disorder processor configured to identify a cardiopulmonary disorder affecting a patient as a breathing rhythm disorder or a non-rhythm breathing disorder; and

a therapy controller coupled to the cardiopulmonary disorder processor and configured to control a therapy delivered to the patient based on the identified cardiopulmonary disorder, wherein at least one of the cardiopulmonary disorder processor and the therapy controller are disposed within the implantable cardiac therapy device;

wherein the one or more pulmonary vasculature disorders comprise pulmonary edema and at least one other type of pulmonary vasculature disorder; and

wherein the cardiopulmonary disorder processor is configured to identify the cardiopulmonary disorder as a pulmonary vasculature disorder including discriminating between the pulmonary edema and the at least one other pulmonary vasculature disorder.

3. A medical therapy control system, comprising:

an external respiratory therapy device comprising a first sensor system configured to sense a first set of one or more physiological conditions and a therapy unit configured to provide positive airway pressure to a patient;

an implantable cardiac therapy device comprising a second sensor system configured to sense a second set of one or more physiological conditions and a therapy unit configured to deliver electrical stimulation to the patient's heart;

a cardiopulmonary disorder processor coupled to the first and the second sensor systems and configured to detect rhythm breathing disorders, including at least apnea, and non-rhythm breathing disorders, including one or more pulmonary vasculature disorders, based on changes in the first set and the second set of sensed physiological conditions, the cardiopulmonary disorder processor configured to identify a cardiopulmonary disorder affecting a patient as a breathing rhythm disorder or a non-rhythm breathing disorder; and

a therapy controller coupled to the cardiopulmonary disorder processor and configured to control a therapy delivered to the patient based on the identified cardiopulmonary disorder, wherein at least one of the cardiopulmonary disorder processor and the therapy controller are disposed within the implantable cardiac therapy device;

wherein the cardiopulmonary disorder processor is configured to identify the cardiopulmonary disorder by discriminating between chronic bronchitis, emphysema, and asthma.

4. A medical therapy control system, comprising:

an external respiratory therapy device comprising a first sensor system configured to sense a first set of one or more physiological conditions and a therapy unit configured to provide positive airway pressure to a patient;

an implantable cardiac therapy device comprising a second sensor system configured to sense a second set of one or more physiological conditions and a therapy unit configured to deliver electrical stimulation to the patient's heart;

a cardiopulmonary disorder processor coupled to the first and the second sensor systems and configured to detect rhythm breathing disorders, including at least apnea, and non-rhythm breathing disorders, including one or more pulmonary vasculature disorders, based on changes in the first set and the second set of sensed physiological conditions, the cardiopulmonary disorder processor configured to identify a cardiopulmonary disorder affecting a patient as a breathing rhythm disorder or a non-rhythm breathing disorder; and

a therapy controller coupled to the cardiopulmonary disorder processor and configured to control a therapy delivered to the patient based on the identified cardiopulmonary disorder, wherein at least one of the cardiopulmonary disorder processor and the therapy controller are disposed within the implantable cardiac therapy device;

wherein the cardiopulmonary disorder processor is configured to identify the non-rhythm breathing disorder including discriminating between pulmonary hypertension, pulmonary edema, and another type of non-rhythm breathing disorder.

5. A medical therapy control system, comprising:

an external respiratory therapy device comprising a first sensor system configured to sense a first set of one or more physiological conditions and a therapy unit configured to provide positive airway pressure to a patient;

an implantable cardiac therapy device comprising a second sensor system configured to sense a second set of one or more physiological conditions and a therapy unit configured to deliver electrical stimulation to the patient's heart;

a cardiopulmonary disorder processor coupled to the first and the second sensor systems and configured to detect rhythm breathing disorders, including at least apnea, and non-rhythm breathing disorders, including one or more pulmonary vasculature disorders, based on changes in the first set and the second set of sensed physiological conditions, the cardiopulmonary disorder processor configured to identify a cardiopulmonary disorder affecting a patient as a breathing rhythm disorder or a non-rhythm breathing disorder; and

a therapy controller coupled to the cardiopulmonary disorder processor and configured to control a therapy delivered to the patient based on the identified cardiopulmonary disorder, wherein at least one of the cardiopulmonary disorder processor and the therapy controller are disposed within the implantable cardiac therapy device;

wherein the cardiopulmonary disorder processor is configured to detect one or more pleural disorders based on the first set and the second set of sensed physiological conditions, the cardiopulmonary disorder processor being further configured to identify the cardiopulmonary disorder as the breathing rhythm disorder, the non-rhythm breathing disorder, or a pleural disorder;

wherein the cardiopulmonary disorder processor is configured to identify the cardiopulmonary disorder as the pleural disorder including discriminating between pleural effusion, pneumothorax, and hemothorax.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2004
From: LEE, KENT; STAHMANN, JEFFREY E.; HARTLEY, JESSE W.; NI, QUAN
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 015780/0826 →
Continuity (3)
Provisional Application 6050447700 · Sep 18, 2003
Provisional Application 6050472300 · Sep 18, 2003
Related Publication 20050065567A1 · Mar 24, 2005